×
App Icon
The Standard e-Paper
Join Thousands Daily
★★★★ - on Play Store
Download App

No safety concerns reported as trials start

Kenyan researchers have successfully begun Covid-19 vaccine trials after the first two participants received the jab developed by the University of Oxford University and AstraZeneca.

Get Full Access for Ksh299/Week.
Uncover the stories others won’t tell. Subscribe now for exclusive access
  • Unlimited access to all premium content
  • Uninterrupted ad-free browsing experience
  • Mobile-optimized reading experience
  • Weekly Newsletters
  • MPesa, Airtel Money and Cards accepted
Already a subscriber? Log in